Other Species / Isoforms
  PLM (dog)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
C60
LIVLSRRCRCKFNQQ
1 0
PLM (human) LIVLSRRCRCKFNQQ C60
PLM (mouse) LIILSKRCRCKFNQQ C60
PLM (rat) LIILSKRcRcKFNQQ C60-pa
PLM (dog) LIVLSRRCRCKFNQQ C60
C62
VLSRRCRCKFNQQQR
1 0
PLM (human) VLSRRCRCKFNQQQR C62
PLM (mouse) ILSKRCRCKFNQQQR C62
PLM (rat) ILSKRcRcKFNQQQR C62-pa
PLM (dog) VLSRRCRCKFNQQQR C62
T79
EPDEEEGTFRSsIRR
0 15
PLM (human) EPDEEEGtFRssIRR T79-p
PLM (mouse) EPDEEEGtFRssIRR T79-p
PLM (rat) EPDEEEGtFRSsIRR T79-p
PLM (dog) EPDEEEGTFRSsIRR T79
S82
EEEGTFRSsIRRLst
0 15
PLM (human) EEEGtFRssIRRLst S82-p
PLM (mouse) EEEGtFRssIRRLss S82-p
PLM (rat) EEEGtFRSsIRRLst S82
PLM (dog) EEEGTFRSsIRRLst S82
S83-p
EEGTFRSsIRRLstR
Upstream
Downstream
21 80
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • PKACA (human)
  • PKCA (human)
  • PKCE (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • phorbol_ester
  • PP1
PLM (human) EEGtFRssIRRLstR S83-p
PLM (mouse) EEGtFRssIRRLssR S83-p
PLM (rat) EEGtFRSsIRRLstR S83-p
PLM (dog) EEGTFRSsIRRLstR S83-p
S88-p
RSsIRRLstRRR___
Upstream
Downstream
26 76
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • PKACA (human)
  • PKCA (human)
  • PKCE (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • colforsin
  • phorbol_ester
  • PP1
  • racepinefrine
PLM (human) RssIRRLstRRR___ S88-p
PLM (mouse) RssIRRLssRRR___ S88-p
PLM (rat) RSsIRRLstRRR___ S88-p
PLM (dog) RSsIRRLstRRR___ S88-p
T89-p
SsIRRLstRRR____
Upstream
8 50
Kinase, in vitro:
  • PKCA (human)
  • PKCE (human)
PLM (human) ssIRRLstRRR____ T89-p
PLM (mouse) ssIRRLssRRR____ S89-p
PLM (rat) SsIRRLstRRR____ T89-p
PLM (dog) SsIRRLstRRR____ T89-p